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Abstract
Introduction—The U.S. spends more than any other country on health care, yet Americans have 
lower life expectancy than most industrialized countries. Recent studies suggest that lower 
expenditures on social policies in the U.S. may contribute to less favorable trends in life 
expectancy. This study tests the hypothesis that greater social spending will be positively 
associated with life expectancy across the countries of the Organisation of Economic Co-operation 
and Development and that the magnitude of these associations will outweigh those between 
government healthcare spending and life expectancy.
Methods—In 2016, longitudinal data on six domains of social expenditures for the U.S. and 19 
other wealthy nations between 1980 and 2010 were used to estimate the associations between prior 
year expenditures on education, family, unemployment, incapacity, old age and active labor market 
programs, and period life expectancy using fixed effects models.
Results—Controlling for a wide set of confounders and government healthcare expenditures, a 
1% increase in prior year education expenditures was associated with 0.160 (95% CI=0.033, 
0.286) of a year gain in life expectancy, whereas a 1% increase in prior year incapacity benefit 
expenditures was associated with 0.168 (95% CI=0.003, 0.333) of a year gain in life expectancy. 
Counterfactual models suggest that if the U.S. were to increase expenditures on education and 
incapacity to the levels of the country with the maximum expenditures, life expectancy would 
increase to 80.12 years.
Conclusions—The U.S. life expectancy lag may be considerably smaller if U.S. expenditures on 
education and incapacity programs were comparable with those in other high-income countries.
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The U.S. spends more than any other country on health care, yet Americans have worse 
health and lower life expectancy than most industrialized countries. In 2016, the U.S. ranked 
42nd in global life expectancy, below most other industrialized nations. Proposed 
explanations include differences in health care, behavior, and the built environment, all of 
which appear to play some role but do not fully explain the U.S. health disadvantage.1 
Recently, focus has shifted towards the potential role of social policy, with reports 
suggesting that lower social expenditures in the U.S. relative to peer nations may contribute 
to less favorable life expectancy trends. As yet, however, few studies have examined whether 
higher social expenditures lead to life expectancy gains.
Emerging research from within the U.S. provides evidence that social expenditures may 
bring benefits to health. In a recent study, a higher ratio of state social welfare spending 
relative to healthcare spending was associated with significant improvements in a variety of 
health outcomes.2,3 Cross-national evidence suggests that several social programs may have 
positive associations with health including parental leave, child allowances and subsidized 
child care,4–6 unemployment benefits, and education.7–10 Experimental evidence from the 
U.S. also suggests that social programs, such as intensive early childhood interventions,11 
might bring some benefits to health, whereas other social investments such as welfare 
reform,12 housing relocation,13 and small class sizes14 had both positive and negative health 
effects. Interestingly, experimental evidence from the Oregon Health Study shows that 
randomized assignment to Medicaid among uninsured Americans led to no significant 
improvement in physical health.15
There are at least three potential mechanisms through which social expenditures may lead to 
better population health. First, higher social spending may insure individuals against 
poverty, which may in turn translate into better health outcomes and lower risk of death. 
Second, social spending may promote human capital investment by increasing access to 
early childhood programs, education, and training, which may translate into better health in 
the long run. Third, social spending may provide reliable safeguards that reduce chronic 
stress pathways linked to hypothalamic–pituitary–adrenal axis dysregulation and subsequent 
metabolic, cardiovascular, and inflammatory changes.
This study uses data from the U.S. and 19 other wealthy nations to examine whether greater 
social spending is associated with larger gains in life expectancy. Associations with health 
are examined across six domains of social spending, accounting for confounding with 
government healthcare spending. The contribution to life expectancy gains of spending on 
social welfare relative to spending on health care is also evaluated. The central hypothesis of 
the study is that greater social spending will be positively associated with life expectancy 
across the countries of the Organisation of Economic Co-operation and Development 
(OECD) and that the magnitude of these associations will outweigh those between 
government healthcare spending and life expectancy.
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Data were drawn from the OECD Social Expenditure Database, which provides yearly data 
on social spending as a percentage of gross domestic product (GDP) spanning 1980 to 2010 
for 20 countries: Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, 
Ireland, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, 
Switzerland, United Kingdom, and the U.S. Data on Australia and Luxembourg were also 
available, but were excluded from the analysis as they did not cover all years and variables 
required for the analysis.
Measures
Data are provided for six domains which represent the largest social expenditures across 
nations and include both cash and in-kind public spending: education, family, 
unemployment, incapacity, old age, and active labor market programs (ALMP). Education is 
the sum of public spending on all levels from pre-primary to tertiary education. Family 
consists of primarily child allowances and credits, childcare support, income support during 
leave, and sole parent payments. Unemployment includes unemployment benefit 
compensation and early retirement programs. Incapacity covers care services, disability 
benefits, benefits accruing from occupational injury and accident legislation, employee 
sickness payments, and home-help and residential services for the working aged. Old age 
largely comprises spending on early retirement pensions and home-help and residential 
services for the elderly. ALMP includes expenditures on employment services, training, 
employment incentives, integration of the disabled, direct job creation, and start-up 
incentives.
Data were drawn from the OECD Health database, which provides internationally 
harmonized data on period life expectancy derived from the WHO Mortality database. 
Period life expectancy measures the average number of years that a person can be expected 
to live from birth, assuming that age-specific mortality levels remain constant.
All models included a linear time trend centered around the first year of observation, GDP 
per capita in millions of U.S. dollars adjusted for inflation (base year 2010), unemployment 
rates measured as the percentage of unemployed out of the total labor force, income 
inequality measured using the Gini coefficient, and variables for the percentage of the 
population age <15 (reference), 15–64, and ≥65 years.
Statistical Analysis
A fixed effects design was employed to address confounding by unmeasured differences 
between countries that are stable over time but might also be correlated with life 
expectancy.16–18 Fixed effects models compare differences in life expectancy across years 
within countries, exploiting only within-country variation in social expenditures for 
estimation. The basic model specification was as follows:
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where yit is a measure of life expectancy for country i at time t, β0 is the intercept, Xitβ is a 
country-level measure of social expenditures and other covariates for country i at time t, υi is 
the unobserved time-invariant characteristics of each country, and εit is the residual for a 
country in a given year.
A test for serial correlation between successive time points was conducted using Stata’s 
xtserial command.19 The null hypothesis of no first-order autocorrelation was rejected at a 
significance level of 0.07. Therefore, models were fit specifying a first-order autoregressive 
process. Specifying a first-order autoregessive process models the error term in equation (1) 
as ρεi,t−1+ ηit., where the absolute value of ρ (rho, the autocorrelation coefficient) is <1 and 
ηit is independent and identically distributed with mean 0 and variance σ2η. To account for 
potential delays in the effect of a given expenditure, models were fit including 
contemporaneous, 1- and 2-year lags of social expenditures. These analyses show the largest 
effect sizes at t−1, pointing to a 1-year lag as the preferred temporal specification of the 
relationship between social spending and life expectancy. All SEs were clustered at the 
country level. Two-tailed tests with an α of 0.05 were used throughout. Analysis was 
conducted in Stata, version 13 and included use of the margins command suite.
RESULTS
Figure 1 shows time trends in the six domains of social expenditure. There has been 
considerable temporal variation. Expenditures on education, family, and incapacity showed 
declines from 1980 to 1990, while old age, ALMP, and unemployment expenditures 
increased during this period. From 1990 to 2000, spending in all domains increased. 
Although spending in education, family, and old-age benefits continued to increase from 
2000 to 2010, spending in unemployment, incapacity, and ALMP declined over the same 
period.
Table 1 shows that within countries there have been substantial changes in expenditures in 
each domain. For example, expenditures on education were as low as 3.5% for New Zealand 
in 1986 in contrast to 7.2% in 2010. In the UK, family expenditures were 1.9% of GDP in 
1990 compared with 3.9% in 2009, the year with the highest family expenditure. 
Expenditures varied considerably between countries as well (Appendix Figure 1). For 
example, maximum expenditures on family benefits was 0.8% of GDP in the U.S. in 2002 
compared with 4.85% in 1992 in Sweden. It is worth noting that the U.S. had the lowest 
average expenditures across all domains, while Sweden had the highest (not shown).
Figure 2 plots life expectancy against social expenditures as percentage of GDP, 
superimposing a local linear smoother upon the data points. With the exception of 
unemployment, the bivariate relationship between social spending and life expectancy is 
positive.
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Table 2 provides estimates from fixed effects models with each domain listed separately. The 
purpose of this table is to test the hypothesis that greater social spending will be positively 
associated with life expectancy and that the magnitude of observed associations will 
outweigh those between government healthcare spending and life expectancy. Greater 
expenditures in the previous year on education (Model 1: b=0.177, 95% CI=0.060, 0.294, 
p<0.001) and incapacity (Model 1: b=0.292, 95% CI=0.154, 0.429, p<0.001) were 
associated with significant gains in life expectancy. Results in Model 2, show that estimates 
of lagged education and incapacity expenditures remained significant in models that 
simultaneously controlled for all domains of social expenditures (b=0.165, 95% CI=0.045, 
0.286, p<0.01, and b=0.172, 95% CI=0.010, 0.334, p<0.05, respectively). Estimates in 
Model 3 show that these results were also robust to additional controls for government 
healthcare expenditures (b=0.160, 95% CI=0.033, 0.286, p<0.05, and b=0.168, 95% 
CI=0.003, 0.333, p<0.05, respectively).
To contextualize these findings, the parameter estimates for prior year education and 
incapacity expenditures are applied to the U.S. case with an observed value of 78.5 in 2009. 
If the U.S. were to increase education spending from 5.4% of GDP to 8.7% of GDP (the 
pooled sample maximum), life expectancy would increase 0.53 years. Increasing incapacity 
spending from 1.71% of GDP to 7.0% of GDP (the pooled sample maximum) would result 
in an increase of 0.89 years in life expectancy. In total, these increases in education and 
incapacity benefits would increase U.S. life expectancy to 80.12 years. Again, the 
specification of these models presumes such expenditures occur the year prior to observation 
of the outcome.
Given its relatively low rates of social spending and life expectancy, models were replicated 
excluding the U.S. The sensitivity of results to the exclusion of Southern European nations, 
which differ from Northern European nations in terms of economic performance and history 
of development, were also tested. Appendix Table 1 (Columns 1 and 2) shows the results of 
these sensitivity analyses. Overall, this table shows that coefficients were nearly identical as 
for the total sample. Results were also robust in models that did not include government-
mandated private expenditures (Column 3) and that incorporated total fertility rate, net 
migration, and population size as additional demographic controls (Column 4).
DISCUSSION
Life expectancy is a key indicator of population health and human development. Results 
from this study show that investments in education and incapacity programs contribute to 
gains in life expectancy and may contribute to the smaller gains in life expectancy observed 
in the U.S. relative to other wealthy nations. These findings suggest that social policies may 
be important determinants of health and life expectancy and may offer an important pathway 
to improving population health.
In this study, the associations between population health and prior year spending on 
education and incapacity were stronger than between population health and spending on 
health care. Although positive, the association with government healthcare spending was 
small in magnitude and not statistically significant in models that controlled for all domains. 
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These findings support the conclusions of Bradley et al.2,3 that spending on social policy 
may be more effective at improving health than spending targeted strictly to health. This 
finding might be because of the fact that the impact of investments in areas of health care 
known to be effective, such as hypertension or cholesterol control, is overshadowed by 
increasing costs in medical technologies or drugs that may be less effective. For example, 
evidence suggests that faster uptake of new and more expensive prescription drugs is an 
important contributor to higher per capita spending in the U.S. relative to other OECD 
countries that employ stricter health technology assessments requiring clear evidence of the 
value of new drugs.21 Although widely publicized, the proposition that costly medical 
technologies ultimately increase U.S. longevity has been challenged by findings suggesting 
that the beneficial effects observed in RCTs are not found when implemented outside of the 
laboratory environment. For a comprehensive treatment of the limitations of, and effective 
companions and alternatives to, RCT-based evidence see the National Academy of 
Medicine’s 2008 report which addressed this and related issues.20
Findings for education are in line with a wealth of evidence suggesting that more schooling 
and higher educational attainment is associated with better health. Education is crucial to 
labor market success,22–27 and may promote healthier behavioral choices28 and increase 
access to social networks, power and prestige, health care, and other mechanisms conducive 
to better health.29 Studies of the Perry School Program in Michigan and The Abecedarian 
program in North Carolina show consistent benefits of intensive early education programs 
on educational, labor market, and cognitive outcomes, all of which predict better health later 
in life.30,31 Studies have also shown that compulsory education laws led to reductions in 
mortality and improvements in health,11,32 although evidence is contradictory for some 
countries, such as Britain and France.33,34 Overall, these results are in line with the 
hypothesis that larger investments in education may lead to gains in life expectancy. 
Increased spending in education may also signal investments to improve the quality of 
education,29 although there is limited evidence on whether these improvements translate into 
health benefits.
Results for incapacity benefits are difficult to interpret. One possibility is that incapacity 
spending addresses the social and economic consequences of poor health and disability, 
which may revert back into benefits to life expectancy. For example, financial resources may 
help incapacitated individuals to effectively manage illness, above and beyond the diagnoses 
and treatments covered under healthcare spending. This could explain why similar 
associations were not observed with unemployment or old-age benefits, which, although also 
a form of income replacement, are not targeted at the already ill and disabled. Even if some 
specific components of family, unemployment, old-age pensions, and ALMP may lead to 
health gains, the current mix of funding allocation across these programs may not translate 
into gains in life expectancy.
Limitations
This study has several strengths, but some limitations should be considered. First, life 
expectancy is driven heavily by infant mortality and there are cross-national differences in 
the reporting of such deaths that could introduce measurement error. Although this may be 
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the case, alternative measures such as survival are likely to disproportionately reflect the 
impact of health care rather than the broad-based impacts of social expenditures that serve as 
the focus of this investigation. Moreover, because these models include country fixed effects, 
they do not compare infant mortality between countries, but rather examine variation over 
time within countries alone. Together, these factors minimize potential measurement-related 
biases.
Second, this analysis investigates the short-term associations between social policy and life 
expectancy. Preliminary analyses suggest a 1-year delay in the effect of expenditures on 
longevity. That said, life expectancy reflects a series of health advantages and insults that 
accumulate over multiple points in the life course. The association between spending and 
life expectancy the following year will not accurately capture the full and long-term 
associations with health and mortality of social investments over a lifetime. In particular, 
investments early in life might lead to long-run benefits for health that only materialize 
decades later. Future studies should explore this question using individual-level data linked 
to aggregate expenditures throughout the life course.
Finally, although time trends and a variety of confounders were included, social expenditure 
variation may also partly reflect unaccounted for demand-side changes. Trends in social 
expenditures similarly reflect a complex pattern of supplyside factors related to the 
adjustment of eligibility and coverage restrictions. For example, mid-1990s welfare reform 
in the U.S. led to a shift of Americans from welfare rolls to Supplementary Security Income. 
Likewise, in many other OECD countries, pension reforms have affected old-age 
expenditures just as benefits and duration caps affected unemployment expenditures. This 
study does not capture the myriad impacts of these types of reforms; however, it does 
provide a sense of how overall changes in social expenditure arising from these policy 
changes relate to life expectancy and helps to set the agenda for future research on the 
subject. Another limitation is that these estimates do not capture changes in the quality of 
predictors or outcomes. In other words, little can be gleaned from these data about the 
caliber of education or life satisfaction during years-of-life gained. Lastly, research on 
poverty and inequality suggests that more universal social expenditures have stronger 
outcome-improvement effects than targeted benefits.38,39 The present analysis, though, does 
not tell whether the magnitude of the observed effects are larger (or smaller) as spending 
levels increase.
Notwithstanding the limitations, these results have important implications for policy. Life 
expectancy gains in the U.S. have slowed significantly in recent decades, even though other 
wealthy nations have continued to enjoy significantly larger gains. This has left the U.S. 
farther and farther down the rankings relative to peer nations.1,36 The fact that increased 
education and incapacity spending are favorably associated with life expectancy gains 
suggests that the comparatively low spending levels in these areas may have contributed to 
this large and growing lag in U.S. life expectancy.
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This study advances knowledge on the relevance of health policy vis-a-vis other policy 
domains. Empirical work has paid considerable attention to the relationship between 
population health and healthcare policy.3,37–42 This is understandable given the intuitive link 
between health care and health. Yet, these findings support prior evidence that health care 
explains only a fraction of gains in life expectancy.43,44 Furthermore, the position of the U.S. 
in international life expectancy rankings does not seem to have benefited from increasingly 
higher overall spending on health care.1,36 These results suggest that the disproportionate 
focus on healthcare policy could shift attention away from other policies outside health care 
that may improve health and reduce mortality in the U.S. and that conceiving social policy 
as health policy may constitute a promising approach to improving population health.
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